CIK 0001359931 · Non-accelerated filer<br>Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 204580525
- Phone
- 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-03 | Bandari Jathin Chief Medical Officer | Shares withheld for taxes | −682 | $2.46 | $2K | 38,460 |
| 2023-06-27 | Shefferman Jesse CEO and President | Gift | −7,420 | 904,453 | ||
| 2023-06-23 | Shefferman Jesse CEO and President | Gift | −1,890 | 911,873 | ||
| 2023-06-07 | GARCEAU ROGER Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2023-06-07 | Smith Cynthia Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2023-06-07 | BESHAR LUKE M Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2023-06-07 | SARGEN GREGORY Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2023-06-07 | Solomon Michael Edward Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2023-06-07 | Levy Richard S Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2023-06-07 | Huang Jane Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2023-06-07 | Flannelly Barry P Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2023-01-30 | Fabbio Patrick Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2023-01-19 | Zummo Jacqueline Chf Scientific Operations Off | Grant or award | +19,900 | 91,473 | ||
| 2023-01-19 | Zummo Jacqueline Chf Scientific Operations Off | Grant or award · Stock Option (Right to Buy) | +119,300 | 119,300 |
Page 8 of 8 · 154 trades